Article
ETAS®50 Attenuates SARS-CoV-2 Spike Protein-Induced IL-6 and IL-1β Production by…
bioRxiv · 2021 · Ken Shirato
Key facts
| Title | ETAS®50 Attenuates SARS-CoV-2 Spike Protein-Induced IL-6 and IL-1β Production by Suppressing p44/42 MAPK and Akt Phosphorylation in Murine Primary Macrophages |
|---|---|
| First author | Ken Shirato |
| Journal | bioRxiv |
| Published | Jul 26, 2021 |
| DOI | 10.1101/2021.07.25.453717 |
| Devices mentioned | K843077, K843710 |
| Product codes mentioned | DGC, LGC |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1